These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7923169)

  • 1. Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model.
    Chang MJ; Yu WD; Reyno LM; Modzelewski RA; Egorin MJ; Erkmen K; Vlock DR; Furmanski P; Johnson CS
    Cancer Res; 1994 Oct; 54(20):5380-6. PubMed ID: 7923169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic enhancement by interleukin-1 alpha of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice.
    Johnson CS; Chang MJ; Yu WD; Modzelewski RA; Grandis JR; Vlock DR; Furmanski P
    Cancer Chemother Pharmacol; 1993; 32(5):339-46. PubMed ID: 8339383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic antitumor activity of cisplatin and interleukin 1 in sensitive and resistant solid tumors.
    Braunschweiger PG; Basrur VS; Santos O; Markoe AM; Houdek PV; Schwade JG
    Cancer Res; 1993 Mar; 53(5):1091-7. PubMed ID: 8439953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.
    Light BW; Yu WD; McElwain MC; Russell DM; Trump DL; Johnson CS
    Cancer Res; 1997 Sep; 57(17):3759-64. PubMed ID: 9288784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of interleukin 1 alpha mediated antitumor effects by ketoconazole.
    Braunschweiger PG; Kumar N; Constantinidis I; Wehrle JP; Glickson JD; Johnson CS; Furmanski P
    Cancer Res; 1990 Aug; 50(15):4709-17. PubMed ID: 2369744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats.
    Ohno S; Strebel FR; Stephens LC; Siddik ZH; Makino M; Klostergaard J; Tomasovic SP; Khokhar AR; Bull JM
    Cancer Res; 1992 Aug; 52(15):4096-101. PubMed ID: 1638521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
    Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
    Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of recombinant human interleukin 1 alpha in RIF-1 and Panc02 solid tumors.
    Braunschweiger PG; Johnson CS; Kumar N; Ord V; Furmanski P
    Cancer Res; 1988 Nov; 48(21):6011-6. PubMed ID: 3262418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of mitomycin C and porfiromycin antitumor activity in solid tumor models by recombinant human interleukin 1 alpha.
    Braunschweiger PG; Jones SA; Johnson CS; Furmanski P
    Cancer Res; 1991 Oct; 51(20):5454-60. PubMed ID: 1913664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented antitumor effects of combination therapy with interleukin-12, cisplatin, and tumor necrosis factor-alpha in a murine melanoma model.
    Zagozdzon R; Stokłosa T; Gołab J; Giermasz A; Dabrowska A; Lasek W; Jakóbisiak M
    Anticancer Res; 1997; 17(6D):4493-8. PubMed ID: 9494557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
    Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
    Teicher BA; Herman TS; Holden SA; Epelbaum R; Liu SD; Frei E
    Cancer Res; 1991 Feb; 51(3):780-4. PubMed ID: 1988117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
    Akamatsu K; Saito H; Tsunenari T; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1993; 13(6A):2261-5. PubMed ID: 8297143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Probability of the combination use of cisplatin and carboplatin].
    Kobayashi K; Hino M; Hayashihara K; Niitani H
    Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2684-92. PubMed ID: 2277219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of carboplatin and cisplatin as potentiators of 5-fluorouracil and radiotherapy in the mouse L1210 leukaemia model.
    Dionet CA; Rapp M; Tchirkov A
    Anticancer Res; 2002; 22(2A):721-5. PubMed ID: 12014642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 1 alpha and gamma-interferon induction of nitric oxide production from murine tumor-derived endothelial cells.
    Chang MJ; Modzelewski RA; Russell DM; Johnson CS
    Cancer Res; 1996 Feb; 56(4):886-91. PubMed ID: 8631029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of carboplatin combined with hyperthermia on Ehrlich-ascites tumor in vivo.
    Mizuuchi H; Yoshiga K; Sakurai K; Tsumura M; Takada K
    Anticancer Res; 1996; 16(1):381-7. PubMed ID: 8615640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice.
    Boughattas NA; Lévi F; Fournier C; Hecquet B; Lemaigre G; Roulon A; Mathé G; Reinberg A
    J Pharmacol Exp Ther; 1990 Nov; 255(2):672-9. PubMed ID: 2243347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.